Medpace Holdings, Inc.

Healthcare / Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.

Performance

--
Today 0.00 (0.00%)
MEDP

Metrics

Market Cap15B
Latest Price$616.44
Previous Close$620.48
Volume173K
52 Week High$628.92
52 Week Low$306.70
52 Week Change68.01%
Average Volume375K
Revenue2.7B
EPS15.88
P/E Ratio33.894
Forward P/E28.545
Price/Book25.691
Profit Margin0.17%
Operating Margin0.20%
Return on Equity0.77%
Dividend Yield0.00%

Recent News for MEDP